BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16552243)

  • 1. Renal cell carcinoma.
    Rini BI; Campbell SC; Rathmell WK
    Curr Opin Oncol; 2006 May; 18(3):289-96. PubMed ID: 16552243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma.
    Rathmell WK; Martz CA; Rini BI
    Curr Opin Oncol; 2007 May; 19(3):234-40. PubMed ID: 17414642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targeted therapy for advanced renal carcinoma: trials in progress.
    Calabrò F; Sternberg CN
    Curr Opin Urol; 2010 Sep; 20(5):382-7. PubMed ID: 20625300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing natural history of renal cell carcinoma.
    Pantuck AJ; Zisman A; Belldegrun AS
    J Urol; 2001 Nov; 166(5):1611-23. PubMed ID: 11586189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokine-based and targeted therapy of metastatic renal cell carcinoma--a current analysis].
    Johannsen M; Ringsdorf M; Römer A; Loening SA; Roigas J
    Aktuelle Urol; 2007 Jan; 38(1):38-45. PubMed ID: 17290328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
    Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma.
    Garcia JA; Cowey CL; Godley PA
    Curr Opin Oncol; 2009 May; 21(3):266-71. PubMed ID: 19339887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New entities in pathological classification and new therapeutic options in renal cell carcinoma].
    Bay JO; Penault-Llorca F; Ravaud A; Chevreau C; Négrier S; Escudier B
    Bull Cancer; 2006 Jan; 93(1):91-100. PubMed ID: 16455511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel investigative approaches for advanced renal cell carcinoma.
    Berg WJ; Divgi CR; Nanus DM; Motzer RJ
    Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
    Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guideline 'Renal cell carcinoma'].
    Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations.
    Klinghoffer Z; Yang B; Kapoor A; Pinthus JH
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):975-87. PubMed ID: 19589036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EORTC-GU group expert opinion on metastatic renal cell cancer.
    de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
    Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-of-the-art surgical management of renal cell carcinoma.
    Thiel DD; Winfield HN
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1285-94. PubMed ID: 17892429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.